USPTO serial 79297909
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Turbine Simulated Cell Technologies Ltd
GB
Other trademarks owned by Turbine Simulated Cell Technologies Ltd
Turbine Simulated Cell Technologies Ltd
GB
Other trademarks owned by Turbine Simulated Cell Technologies Ltd
Turbine Simulated Cell Technologies Ltd
GB
Other trademarks owned by Turbine Simulated Cell Technologies Ltd
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and assays for molecular biology and medicinal chemistry research purposes; biological preparations for use in industry and science; chemical and biochemical reagents and assays for molecular biology and medicinal chemistry research use | ACTIVE | — |
| 005 | Medical and veterinary preparations for therapeutic purposes for the treatment of cancer; therapeutic preparations for cell treatment; preparations for modifying human and animal cells for medical and therapeutic purposes; biological, chemical and biochemical reagents and assays for medical research use being the testing of body compositions | ACTIVE | — |
| 009 | Downloadable cloud based computer software for molecular biology and medicinal chemistry research; Downloadable cloud based bioinformatics software for molecular biology and medicinal chemistry research; Downloadable cloud based computer software platforms for molecular biology and medicinal chemistry research; scientific apparatus for measuring and analysing scientific data; data analysis apparatus incorporating computer software; Downloadable cloud based data analysis software for molecular biology and medicinal chemistry research; Downloadable cloud based computer software artificial intelligence platforms for machine learning; Downloadable cloud based databases in the field of molecular biology and medicinal chemistry research; Downloadable cloud based computer software for creating biological simulations; Downloadable cloud based computer computational simulation and modelling software; Downloadable cloud based computer software for storing and processing biological data; Downloadable cloud based computer computational biomodelling software; Downloadable cloud based computer software for developing algorithms and models of biological systems and relationships; Downloadable cloud based computer software for computational biology; Downloadable cloud based computer software for biological cell modelling | ACTIVE | — |
| 042 | Scientific and technological research and design in the field of molecular biology and medicinal chemistry; scientific and technological services and research and design relating thereto, namely, providing non-downloadable computer software for molecular biology and medicinal chemistry research, non-downloadable computer software for molecular biology and medicinal chemistry research, non-downloadable bioinformatics software for molecular biology and medicinal chemistry research, non-downloadable computer software platforms for molecular biology and medicinal chemistry research, non-downloadable data analysis software for molecular biology and medicinal chemistry research, non-downloadable computer software artificial intelligence platforms for machine learning, non-downloadable databases in the field of molecular biology and medicinal chemistry research, non-downloadable computer software for creating biological simulations, non-downloadable computer computational simulation and modelling software, non-downloadable computer software for storing and processing biological data, non-downloadable computer computational biomodelling software, non-downloadable computer software for developing algorithms and models of biological systems, non-downloadable computer software for computational biology and non-downloadable computer software for biological cell modelling; scientific research in human and animal biological systems; design and development of new products, namely, molecular biology and medicinal chemistry simulation software for internal use; scientific laboratory services; computational biology services; computational cell modelling services; Scientific and technological services, namely, analyzing scientific and technical data in the fields of molecular biology and medicinal chemistry; development of computer programs for simulating laboratory experiments; bioinformatics services; scientific research featuring computational biomodeling services; providing online non-downloadable software platforms incorporating artificial intelligence; software as a services (SaaS) featuring software for machine learning in the fields of molecular biology and medicinal chemistry; hosting computer application software in the field of knowledge management for creating searchable databases of information and data; software as a service in the field of biological simulations and computational biology and biomodelling; scientific research services, namely, running biological simulations for others; scientific research services, namely, developing algorithms and models of biological systems and relationships; advisory and consultancy relating to all the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 15, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 9, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 4, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |